Christopher Meldrum

Christopher Meldrum is an entrepreneur in residence at DCVC Bio. Christopher previously served as managing director at Golden Pine Ventures, where they sought out biotechnology and biomedical opportunities developed by leading researchers and grew them into valuable businesses. Prior to that, Meldrum was director of corporate alliances at Paradigm Genetics, where they negotiated long-term research collaborations with pharmaceutical, large agrochemical, and biotechnology companies, leveraging Paradigm's genomics and metabolomics platforms. Christopher also played a major role in developing corporate strategy for Paradigm's Healthcare business, both near- and long-term. Meldrum has negotiated to completion 7 revenue-generating research collaborations with combined deal values over $30 million (not including royalties) and completed 14 additional agreements with combined deal values over $11.2 million.

Christopher Meldrum's educational career includes obtaining an MBA in Finance from the University of Minnesota - Carlson School of Management, a Bachelor of Arts in Chemistry with a Biochemistry Emphasis from the University of Utah, and studying at Luiss Guido Carli University and Highland High School.

Christopher Meldrum reports to John Hamer, Managing Partner, DCVC Bio. Some of their coworkers include Andy May - Entrepreneur In Residence, DCVC Bio, Anna Fokina - Investment Director, DCVC Bio, and Eric Shiozaki - Partner, DCVC Bio.